CytomX Therapeutics, Inc.
CTMX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,229 | -$154 | $23,525 | $18,876 |
| Dep. & Amort. | $134 | $347 | $385 | $413 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,500 | $1,431 | $2,008 | $1,884 |
| Change in WC | $622 | -$18,088 | -$47,588 | -$41,457 |
| Other Non-Cash | -$3,575 | $711 | $627 | $376 |
| Operating Cash Flow | -$15,548 | -$15,753 | -$21,043 | -$19,908 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $127 | -$27 | -$119 | -$80 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$108,833 | -$19,785 | -$49,784 |
| Inv. Sales/Matur. | $0 | $32,500 | $50,500 | $64,999 |
| Other Inv. Act. | $312 | $0 | $0 | $0 |
| Investing Cash Flow | $439 | -$76,360 | $30,596 | $15,135 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $93,550 | $0 | $2,066 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $253 | $0 | $0 | $183 |
| Financing Cash Flow | $253 | $93,550 | $0 | $2,249 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$14,856 | $1,437 | $9,553 | -$2,524 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $50,069 | $48,632 | $39,079 | $41,603 |
| End Cash | $35,213 | $50,069 | $48,632 | $39,079 |
| Free Cash Flow | -$15,421 | -$15,780 | -$21,162 | -$19,988 |